Haemonetics (HAE) Misses Q2 EPS by 1c, Lowers FY EPS Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.07 +0.29%
EPS Growth %: -0.9%
Financial Fact:
Net income: 0.38
Today's EPS Names:
CRMT, More
EPS Growth %: -0.9%
Financial Fact:
Net income: 0.38
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.60, $0.01 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $239.9 million versus the consensus estimate of $239.99 million.
GUIDANCE:
Haemonetics sees FY2022 EPS of $2.40-$2.65, versus the consensus of $2.76.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
- Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
